Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Employer
- Pfizer
- University of Maryland, Baltimore
- Nature Careers
- Uppsala University
- Aix-Marseille Université
- Monash University
- University of California, San Francisco
- Cincinnati Children's Hospital
- Duke University
- Northeastern University
- UNIVERSITE DE LIMOGES
- University of California
- University of California San Francisco
- University of Gothenburg
- University of North Texas Health Science Center at Fort Worth
- Uppsala universitet
- 6 more »
- « less
-
Field
-
the INCa-labeled center for early phase clinical trials (CLIP2). This joint project-team, built on strong expertise in mathematical modeling, pharmacometrics and experimental and clinical oncology, is
-
, playing a key role in shaping the future of pharmacy in both Sweden and globally. Our scientific focus areas include Pharmacokinetics & Pharmacodynamics • Pharmacometrics • Drug Delivery • Molecular
-
ROLE SUMMARY Supporting Pfizer Oncology, you will be a senior scientific and strategic leader and a member of the Pharmacometrics and Systems Pharmacology Leadership Team. In this key role, you will
-
Open Rank Pharmacy School Assistant, Associate, or Professor (Pharmacometrics), Non-Tenure Track - (2300013B) Location: On-site at the University of Maryland School of Pharmacy, Baltimore, Maryland
-
, pharmacometrics tools, software, hardware, and/or related business processes ROLE RESPONSIBILITIES With guidance, provide MIDD expertise on multidisciplinary development teams, working closely with clinical
-
clinical drug development in collaboration with pharmacometrics and statistics groups (as relevant). Provides recommendations for clinical doses and dosing regimens (including drug-drug interactions, food
-
research and development principles, with a focus on computational biology, biological systems modeling, and pharmacometrics. We are looking to enhance the group’s platform development capabilities with
-
pharmacology, pharmacogenetics/genomics, pharmacometrics, and quantitative systems pharmacology. It will serve as a bridge between the discovery sciences and the use of novel pharmacological interventions
-
pharmacology, pharmacogenetics/genomics, pharmacometrics, and quantitative systems pharmacology. It will serve as a bridge between the discovery sciences and the use of novel pharmacological interventions
-
throughout clinical drug development in collaboration with pharmacometrics and statistics (as relevant). Provides recommendations for clinical doses and dosing algorithms (including drug interaction advice